Elanco Animal Health, Inc. (ELAN)

23.53 +0.40 (+1.73%) USD  |  NYSE  |  Apr 17, 14:14
More

Elanco Animal Health Research and Development Expense (Quarterly) : 93.00M for Dec. 31, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Zoetis, Inc. 199.00M
Eli Lilly & Co. 3.802B
Gilead Sciences, Inc. 1.565B
Hims & Hers Health, Inc. 40.96M
Moderna, Inc. 708.00M